New compounds may treat both alcohol and cigarette addictions

November 3, 2010

Researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco, and Pfizer Inc., have determined that two new compounds may be effective in treating both alcohol and nicotine dependence at the same time.

In a paper published in the November 3, 2010 issue of Neuropsychopharmacology, the researchers showed that in rodents was significantly decreased by two compounds that target neuronal nicotinic acetylcholine receptor (nAChR) subtype {alpha}3{beta}4*.

nAChRs are proteins found in the brain and broader that mediate the effects of substances such as nicotine. Recent human genetic studies have shown that the genes encoding the {alpha}3{beta}4* subtype are of significant importance for susceptibility to both and nicotine dependence.

"The problem has been translating these important genetic findings into more effective medications for people," said co-senior author Selena E. Bartlett, PhD, director of the Preclinical Development group at the Gallo Center. The lead author of the study is Susmita Chatterjee, PhD, of the Gallo Center.

The work was done in collaboration with scientists led by co-senior author Hans Rollema, PhD, in the Neuroscience Research Unit at Pfizer Inc.

One of the new compounds, CP-601932, has been shown in a clinical study to be safe in humans, notes Bartlett. She recommends a clinical study to evaluate the compound's efficacy and potential benefits in treating both alcohol and nicotine dependence.

The other compound is PF-4575180. Both were developed by Pfizer.

"Alcohol and addiction are often treated as separate disorders," Bartlett says, "despite the fact that 60 to 80 percent of heavy drinkers smoke tobacco. There are very few effective strategies for treating these disorders separately, let alone together. Our data suggest that by targeting specific nAChR subtypes, it may be possible to treat both alcohol and with one medication."

Significantly, while the compounds had a significant effect on the rodents' alcohol consumption, their intake of sucrose was not affected. "This indicates that unlike currently approved alcohol abuse medications, the compounds do not interfere with the brain's natural reward system in a larger way," says Bartlett.

Related Stories

Recommended for you

Deep brain stimulation may not boost memory

December 7, 2016

Deep brain stimulation (DBS) of areas in the brain known to be involved in making memories does not improve memory performance, according to a study by Columbia University researchers published December 7 in Neuron. The study ...

Knowing one's place in a social hierarchy

December 7, 2016

When you start a new job, it's normal to spend the first day working out who's who in the pecking order, information that will come in handy for making useful connections in the future. In an fMRI study published December ...

When neurons are 'born' impacts olfactory behavior in mice

December 7, 2016

New research from North Carolina State University shows that neurons generated at different life stages in mice can impact aspects of their olfactory sense and behavior. The work could have implications for our understanding ...

Rhythm of breathing affects memory and fear

December 6, 2016

Northwestern Medicine scientists have discovered for the first time that the rhythm of breathing creates electrical activity in the human brain that enhances emotional judgments and memory recall.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.